A Q2 2019 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q2 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.2B+2.7% YoY

Gross Profit

$669M54.0% margin

Operating Income

$216M17.4% margin

Net Income

$182M14.7% margin

EPS (Diluted)

$0.57

QoQ Revenue Growth

-3.6%

Cash Flow

Operating Cash Flow

$252M

Free Cash Flow

$213M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$9.0B

Total Liabilities

$3.9B

Stockholders' Equity

$5.1B

Cash & Equivalents

$2.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	+2.7%
Gross Profit	$669M	$644M	+3.9%
Operating Income	$216M	$210M	+2.9%
Net Income	$182M	$205M	-11.2%

Revenue Segments

Life Sciences and Applied Markets

$529M43%

Agilent CrossLab

$455M37%

Diagnostics and Genomics

$254M21%

Geographic Segments

Asia Pacific

$451M36%

Americas

$433M35%

Europe

$354M29%